JDRF Strategic Research Agreement - Novel Adjunctive Therapeutic For T1D; a-MSH/MC5R agonist axis

Cowley, Michael (Primary Chief Investigator (PCI))
Sleeman, Mark (Chief Investigator (CI))
Thompson, Philip (Chief Investigator (CI))
Wentworth, John (Chief Investigator (CI))
Kelly, Lauren (Project Manager)

Physiology
Monash Biomedicine Discovery Institute
Medicinal Chemistry

Project: Research

Project Description

This proposal aims to test if α-MSH reduces blood glucose in people with type 1 diabetes, without affecting basal glucose levels, and to generate stable, specific analogues as lead drug development candidates.

Short title	α-MSH/MC5R axis as an adjunctive therapeutic target for type 1 diabetes
Status	Active
Effective start/end date	1/07/19 → 30/09/25

Animal Research Platform (MARP)
Findlay, C. (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility

JDRF Strategic Research Agreement - Novel Adjunctive Therapeutic For T1D; a-MSH/MC5R agonist axis

Project Details

Project Description

Equipment

Animal Research Platform (MARP)